[go: up one dir, main page]

MX2009006823A - Formas de dosificacion solidas de desintegracion oral que comprenden progestina y metodos para hacer y usar las mismas. - Google Patents

Formas de dosificacion solidas de desintegracion oral que comprenden progestina y metodos para hacer y usar las mismas.

Info

Publication number
MX2009006823A
MX2009006823A MX2009006823A MX2009006823A MX2009006823A MX 2009006823 A MX2009006823 A MX 2009006823A MX 2009006823 A MX2009006823 A MX 2009006823A MX 2009006823 A MX2009006823 A MX 2009006823A MX 2009006823 A MX2009006823 A MX 2009006823A
Authority
MX
Mexico
Prior art keywords
dosage forms
progestin
making
methods
orally disintegrating
Prior art date
Application number
MX2009006823A
Other languages
English (en)
Inventor
Tahseen A Chowdhury
Salah U Ahmed
Sundeep Sethia
Original Assignee
Duramed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duramed Pharmaceuticals Inc filed Critical Duramed Pharmaceuticals Inc
Publication of MX2009006823A publication Critical patent/MX2009006823A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se dirige a formas de dosificación farmacéuticas sólidas de desintegración oral, no efervescentes que comprenden progestina y métodos para hacer y usar las formas de dosificación para tratar afecciones en mujeres en necesidad de las mismas.
MX2009006823A 2006-12-20 2007-12-20 Formas de dosificacion solidas de desintegracion oral que comprenden progestina y metodos para hacer y usar las mismas. MX2009006823A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87582706P 2006-12-20 2006-12-20
PCT/US2007/025974 WO2008079245A2 (en) 2006-12-20 2007-12-20 Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof

Publications (1)

Publication Number Publication Date
MX2009006823A true MX2009006823A (es) 2009-07-03

Family

ID=39563076

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006823A MX2009006823A (es) 2006-12-20 2007-12-20 Formas de dosificacion solidas de desintegracion oral que comprenden progestina y metodos para hacer y usar las mismas.

Country Status (11)

Country Link
US (2) US7867515B2 (es)
EP (1) EP2124900B1 (es)
JP (1) JP5649305B2 (es)
AU (1) AU2007338843B2 (es)
BR (1) BRPI0719486A2 (es)
CA (1) CA2674776A1 (es)
ES (1) ES2531929T3 (es)
IL (1) IL199472A0 (es)
MX (1) MX2009006823A (es)
RU (1) RU2465907C2 (es)
WO (1) WO2008079245A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8865144B2 (en) * 2006-02-14 2014-10-21 The Procter & Gamble Company Personal care compositions comprising responsive particles
AU2007338843B2 (en) * 2006-12-20 2013-05-09 Teva Women's Health, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
FR2937862B1 (fr) * 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
US9616073B2 (en) * 2009-04-14 2017-04-11 Laboratoire Hra-Pharma Method for on-demand contraception
AU2012264602B2 (en) 2011-06-01 2017-03-09 Estetra Srl Process for the production of estetrol intermediates
SG195121A1 (en) 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
JP5928159B2 (ja) * 2012-05-28 2016-06-01 ニプロ株式会社 医薬組成物
FR2997627B1 (fr) 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
HRP20180129T1 (hr) * 2013-12-12 2018-02-23 Donesta Bioscience B.V. Oralno raspadajuća čvrsta jedinica doze koja sadrži estetrol komponentu
CN103877048A (zh) * 2014-03-26 2014-06-25 邵娜 一种黄体酮口腔崩解片及其制备方法
US9988669B2 (en) 2014-04-14 2018-06-05 Abbott Molecular Inc. Medium used for blood sample collection and transport
JP6813150B2 (ja) 2015-06-18 2021-01-13 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロールを含有する口腔内崩壊錠
SI3310345T1 (sl) 2015-06-18 2021-05-31 Estetra Sprl Orodisperzibilna tableta, ki vsebuje estetrol
SMT202200102T1 (it) 2015-06-18 2022-05-12 Estetra Srl Unità di dosaggio orodispersibile contenente un componente di estetrolo
DK3106148T3 (en) 2015-06-18 2018-05-07 Mithra Pharmaceuticals S A Orodispersible dosing unit containing an estetrol component
CN107595788B (zh) * 2016-07-11 2020-08-21 武汉朗来科技发展有限公司 一种用于口服固体制剂的复合崩解剂体系及含有该复合崩解剂体系的口服固体制剂
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN109276550B (zh) * 2018-11-27 2021-01-12 西安圣雪沙药物开发有限公司 一种左炔诺孕酮片及其制备方法
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
MX2023003432A (es) 2020-09-29 2023-08-04 Millicent Pharma Ltd Formulaciones orodispersables.
WO2022225986A1 (en) * 2021-04-19 2022-10-27 Archer David Fitzgerald On demand female contraceptive

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
WO1997042959A1 (en) * 1996-05-16 1997-11-20 Gynétics Inc. Emergency contraceptive kit
JPH1171268A (ja) * 1997-08-28 1999-03-16 Kayaku:Kk 性ホルモン含有錠剤
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
US6368625B1 (en) * 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
EP1161941A4 (en) * 1999-03-15 2002-08-28 Kaken Pharma Co Ltd QUICKLY DISMANTLING TABLETS AND METHOD FOR THE PRODUCTION THEREOF
US6667050B1 (en) * 1999-04-06 2003-12-23 Galen (Chemicals) Limited Chewable oral contraceptive
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
SI1355644T1 (sl) * 2001-01-26 2006-10-31 Schering Corp Uporaba substituiranih azetidinonskih spojin za zdravljenje sitosterolemije
HU227198B1 (en) * 2001-11-27 2010-10-28 Richter Gedeon Nyrt Pharmaceutical composition for emergency contraception containing levonorgestrel
US6962908B2 (en) * 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
US7749533B2 (en) * 2003-05-07 2010-07-06 Akina, Inc. Highly plastic granules for making fast melting tablets
US8647668B2 (en) * 2003-10-15 2014-02-11 Fuji Chemical Industry Co., Ltd. Tablet quickly disintegrating in oral cavity
JP4519444B2 (ja) * 2003-10-31 2010-08-04 ライオン株式会社 口腔内崩壊錠
CA2548822C (en) * 2003-12-08 2015-08-11 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN1634077A (zh) * 2004-11-18 2005-07-06 王立强 左炔诺孕酮口腔崩解片制剂及其制备方法
PL385455A1 (pl) * 2005-04-22 2008-11-24 Teva Pharmaceuticals Usa,Inc. Doustna rozpadająca się farmaceutyczna tabletka preparatów olanzapiny
WO2006128057A2 (en) * 2005-05-26 2006-11-30 Duramed Pharmaceuticals, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
AU2007338843B2 (en) * 2006-12-20 2013-05-09 Teva Women's Health, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"

Also Published As

Publication number Publication date
IL199472A0 (en) 2010-03-28
US20080175906A1 (en) 2008-07-24
EP2124900B1 (en) 2014-12-03
EP2124900A4 (en) 2013-04-03
BRPI0719486A2 (pt) 2014-02-18
RU2009125972A (ru) 2011-01-27
US20110136771A1 (en) 2011-06-09
US8226980B2 (en) 2012-07-24
WO2008079245A3 (en) 2008-12-04
RU2465907C2 (ru) 2012-11-10
JP5649305B2 (ja) 2015-01-07
JP2010513514A (ja) 2010-04-30
ES2531929T3 (es) 2015-03-20
AU2007338843A1 (en) 2008-07-03
EP2124900A2 (en) 2009-12-02
US7867515B2 (en) 2011-01-11
WO2008079245A2 (en) 2008-07-03
AU2007338843B2 (en) 2013-05-09
CA2674776A1 (en) 2008-07-03

Similar Documents

Publication Publication Date Title
MX2009006823A (es) Formas de dosificacion solidas de desintegracion oral que comprenden progestina y metodos para hacer y usar las mismas.
MX2009009428A (es) Analogos de ciclopamina heterociclicos y metodos de uso de los mismos.
PH12011502704A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
WO2012064667A3 (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
MX2020004099A (es) Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
MX350761B (es) Inhibidores de isoindolinona de fosfatidilinositol 3-cinasa.
TN2009000444A1 (en) Combination therapy with a compound acting as a plateletadp receptor inhibitor
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
UA103915C2 (ru) Твердая лекарственная форма, которая содержит линаглиптин и ингибитор sglt2, и ее применение
GB0906579D0 (en) Pharmaceuticals, compositions and methods of making and using the same
MX2011011950A (es) Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas.
MX2010000098A (es) Derivados de guanina policiclicos y sus metodos de uso.
WO2010068794A3 (en) Hif inhibitors and use thereof
IN2012DN02471A (es)
MX2011011109A (es) Formulaciones orales de bendamustina.
TW200738669A (en) Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide
NO20092143L (no) Anvendelse av testosteron og en 5-HT1A-agonist ved behandling av seksuell dysfunksjon
PH12012501389A1 (en) Hedgehog inhibitors
EP2328550A4 (en) MUCOADHERENT COMPOSITIONS AND THEIR USE
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
MX2011008645A (es) Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa.
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
AR070392A1 (es) Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de eleboracion

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration